RJA
CTVA icon

Ross\Johnson & Associates’s Corteva CTVA Stock Holding History

Ross\Johnson & Associates’s Portfolio CTVA Stock Details CTVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$251 Sell
3
-7
-70% -$527 ﹤0.01% 160
2025
Q4 		$670 Buy
10
+7
+233% +$453 0.01% 121
2025
Q3 		$203 Hold
3
– – ﹤0.01% 170
2025
Q2 		$224 Sell
3
-29
-91% -$1.93K ﹤0.01% 162
2025
Q1 		$2.01K Buy
+32
New +$1.98K 0.03% 167

Other funds holding CTVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Ross\Johnson & Associates's CTVA Position: Q1 2026 in Review

Ross\Johnson & Associates reduced its Corteva (CTVA) stake by 70% in Q1 2026, selling an estimated $527 and leaving 3 shares worth $251. The position accounts for ﹤0.01% of the portfolio, ranked #160.

Ross\Johnson & Associates first reported a position in CTVA in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.01K in Q1 2025. 1,476 funds tracked by Wall St. Rank hold CTVA as of Q1 2026.

  • Ross\Johnson & Associates held 3 shares of Corteva worth $251 as of Q1 2026.
  • Ross\Johnson & Associates sold 7 Corteva shares in Q1 2026, an estimated $527.
  • Corteva made up ﹤0.01% of Ross\Johnson & Associates's portfolio in Q1 2026, its #160 holding.
  • Ross\Johnson & Associates first reported a position in Corteva in Q1 2025 and has held it in 5 quarters since.
  • Ross\Johnson & Associates's Corteva position peaked at $2.01K in Q1 2025.
  • 1,476 funds tracked by Wall St. Rank held Corteva as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.